This course discusses that demonstrated the feasibility of applying the droplet digital PCR platform in minimal residual disease monitoring, allowing clinicians to make prompt decisions for early signs of relapsing leukemia.al disease control.

Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.